ADC |
Antibody Drug Coniugated |
BC |
Breast Cancer |
BL1/2 |
Basal-Like 1/2 |
BRCA1/2
|
BReast CAncer type 1 and Type 2 |
CSCs |
Cancer Stem Cells |
CTCs |
Circulating Tumor Cells |
dMMR |
Mismatch Repair deficiency |
DSBs |
DNA Double Strand Breaks |
DCs |
Dendritic Cells |
DFS |
Disease Free Survival |
EMT |
Epithelial Mesenchymal Transition |
ER |
Estrogen Receptor |
FDA |
Food and Drug Administration |
FFPE |
Formalin-fixed paraffin embedded |
GEP |
Gene Expression Profile |
gBRCAm |
germline BRCA mutations |
GPNMB |
Glycoprotein non-metastatic b |
HBOC |
Hereditary Breast and Ovarian Cancer Syndrome |
HRD |
Homologous Recombination Deficiency |
HRD-LOD |
HRD-Loss of Heterozygosity |
HRD-LST |
HDR-Large Scale Transition |
HRD-TAI |
HDR-Telomeric Allelic Imbalance |
HER2 |
Human Epidermal Growth Factor Receptor 2 |
HR |
Homologous Recombination |
HRR |
Homologous Recombination Repair |
IC |
Immune Cells |
ICI |
Immune Checkpoint Inhibitor |
IM |
Immunomodulatory |
LAG3 |
Lymphocyte-associated gene 3 |
LAR |
Luminal Androgen Receptor |
MAP |
Mitogen-Activated Protein |
MBC |
Metastatic Breast Cancer |
MHC |
Major Histocompatibility Complex |
MMAE |
Microtubule-disrupting agent monomethyl auristatin E |
MMR |
Mismatch Repair |
MSI |
Microsatellite Instability |
MSI-H |
High Microsatellite Instability |
MSL |
Mesenchymal Stem-Like |
mTOR |
Mammalian Target Of Rapamycin |
mTORC1 |
mTOR complex 1 |
NGS |
Next Generation Sequencing |
NHEJ |
Non-Homologous End Joining |
NK |
Natural Killer |
ORR |
Objective Response Rate |
OS |
Overall Survival |
OXPHOS |
Oxidative Phosphorylation |
pCR |
Pathological Complete Response |
PARP |
Poly ADP-ribose polymerase |
PARPi |
Poly ADP-ribose polymerase Inhibitors |
PD-1 |
Programmed Cell Death-1 |
PD-L1 |
Programmed Cell Death Ligand-1 |
PDX |
Patient-Derived-Xenograft |
PFS |
Progression Free Survival |
PI3K |
Phosphatidylinositol 3-kinase |
PIK3CA |
Phosphatidylinositol-4, 5-bisphosphate 3-kinase, catalytic subunit, alpha |
PIP3 |
Phosphatidylinositol (3,4,5)-trisphosphate |
PTEN |
Phosphatase and Tensin Homolog |
PR |
Progesterone Receptor |
RCB |
Residual Cancer Burden |
sBRCAm |
Somatic BRCA mutations |
TC |
Tumor Cells |
TIL |
Tumor Infiltrating Lymphocytes |
TMB |
Tumor Mutational Burden |
TNBC |
Triple Negative Breast Cancer |
UNS |
Unstable |